statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nautilus Biotechnology, Inc. (NASDAQ:NAUT  Get Free Report) CEO Sujal M. Patel bought 18,854 shares of the firms stock in a transaction on Thursday, March 7th. The stock was purchased...

Insider Buying: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) CEO Acquires 18,854 Shares of Stock

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Nautilus Biotechnology assumed with an Equal Weight at Morgan Stanley

Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript...

Nautilus Biotechnology, Inc. (NAUT) Q4 2023 Earnings Call Transcript

Nautilus Biotechnology reports Q4 EPS (14c), consensus (14c)

SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus ), a company pioneering a single molecule proteome analysis platform, today reported financial...

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus ), a company pioneering a single-molecule protein analysis platform, today announced the company...

Nautilus Biotechnology to Participate in the TD Cowen 44  Annual Healthcare Conference

SkyWater signs production agreement with Nautilus Biotechnology...

SkyWater signs production agreement with Nautilus Biotechnology

Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.

Volume	107,897.00
52-Wk High	$4.65
52-Wk Low	$2.16

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.17	--	--	N/A
Q1'24	-$0.16	-$0.15	7.69%	BEAT
Q4'23	-$0.16	-$0.14	11.11%	BEAT
Q3'23	-$0.16	-$0.13	16.13%	BEAT
Q2'23	-$0.15	-$0.13	13.33%	BEAT

NAUT Nautilus Biotechnology Inc

About

Feed

News

Sentiment

Earnings

Fundamentals